Compare BHM & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHM | CCEL |
|---|---|---|
| Founded | 2022 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Managed Health Care |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.9M | 32.7M |
| IPO Year | 2022 | 2022 |
| Metric | BHM | CCEL |
|---|---|---|
| Price | $11.70 | $3.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 7.8K | ★ 12.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.73% | 4.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $68,734,000.00 | $25,384,279.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 36.88 | 9.76 |
| 52 Week Low | $8.05 | $3.10 |
| 52 Week High | $14.81 | $7.70 |
| Indicator | BHM | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 64.55 | 38.45 |
| Support Level | $10.52 | $3.13 |
| Resistance Level | $12.04 | $3.57 |
| Average True Range (ATR) | 0.83 | 0.09 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 63.64 | 25.27 |
Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The Company is an externally managed REIT managed and advised by Bluerock Homes Manager, LLC.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.